Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Synthesis and use of new heterocyclic antiinflammatory agents described by Boehringer Ingelheim

Sep. 12, 2000

Bayer identifies potent, orally active phenyl pyrazolyl urea p38 kinase inhibitors

Sep. 12, 2000

Novel N-hydroxyformamide inhibitor of TACE and TNF production: GW-4459

Sep. 6, 2000

Health Canada requests additional clinical data for Pennsaid NDS

Sep. 4, 2000

Matrix metalloproteinase inhibitors reported by Fujisawa

Sep. 1, 2000

Alexion completes enrollment of 5G1.1 phase II study, begins open-label extension study

Sep. 1, 2000

SmithKline Beecham reports compounds useful for treating cytokine-mediated disorders

Aug. 30, 2000

Stem cell transplantation induces remission in persistent SLE

Aug. 30, 2000

FDA accepts Celebrex sNDA for filing

Aug. 28, 2000

Inhibitors of p38MAP kinase under development at Teikoku Hormone

Aug. 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...